4//SEC Filing
PRICE MICHAEL DENNIS 4
Accession 0001104659-19-051596
CIK 0000827809other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 6:30 PM ET
Size
5.5 KB
Accession
0001104659-19-051596
Insider Transaction Report
Form 4
PRICE MICHAEL DENNIS
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2019-09-24$0.76/sh−3,926$2,984→ 14,111 total
Footnotes (1)
- [F1]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units. The vesting event occurred as the result of the acceleration of vesting on all outstanding equity awards under the Issuer's equity plans upon the closing of the previously announced transaction between, inter alia, the Issuer's operating subsidiary, Aegerion Pharmaceuticals, Inc. ("Aegerion") and Amryt Pharma plc on September 24, 2019. As a result of the transaction, the Issuer was divested of Aegerion, which constituted a change of control or sale event under the Issuer's equity plans.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001247313
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 6:30 PM ET
- Size
- 5.5 KB